uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
17.27
+0.66 (3.97%)
At close: Jun 6, 2025, 4:00 PM
17.27
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:58 PM EDT
uniQure Revenue
uniQure had revenue of $1.57M in the quarter ending March 31, 2025, a decrease of -81.53%. This brings the company's revenue in the last twelve months to $20.20M, up 6.30% year-over-year. In the year 2024, uniQure had annual revenue of $27.12M with 71.17% growth.
Revenue (ttm)
$20.20M
Revenue Growth
+6.30%
P/S Ratio
40.97
Revenue / Employee
$96,656
Employees
209
Market Cap
945.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.12M | 11.28M | 71.17% |
Dec 31, 2023 | 15.84M | -90.64M | -85.12% |
Dec 31, 2022 | 106.48M | -417.52M | -79.68% |
Dec 31, 2021 | 524.00M | 486.49M | 1,296.82% |
Dec 31, 2020 | 37.51M | 30.23M | 415.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
QURE News
- 4 days ago - uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease - GlobeNewsWire
- 9 days ago - uniQure's AMT-130 Gene Therapy Warrants An Upgrade - Seeking Alpha
- 18 days ago - Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair - GlobeNewsWire
- 27 days ago - uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 4 weeks ago - uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data - Seeking Alpha
- 4 weeks ago - uniQure to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130 - Seeking Alpha